“...pleasure and pain, they come and go and don't last... bear them patiently”
—Gita
Pathos InvestmentsEquity Research
Research  ›  Fact Sheets  ›  LYB

LYONDELLBASELL INDUSTRIES N.V.

LISTEDNYSE
SYMBOLLYB
SIC2860
STATE OF INC.P7
FISCAL YEAR ENDSDecember 31
CIK1489393

INDUSTRIAL ORGANIC CHEMICALS · LARGE ACCELERATED FILER · 10 FISCAL YEARS OF SEC XBRL DATA, 2016–2025

REVENUES, NET INCOME AND FREE CASH FLOW BY FISCAL YEAR$ billions-2002040602016201720182019202020212022202320242025RevenuesNet incomeFree cash flowEARNINGS AND DIVIDENDS PER SHARE$ per share-5.000.005.0010.0015.0020.002016201720182019202020212022202320242025EPS dilutedDividends per share

Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures as reported.

CAPITALIZATION 12/31/25

($ millions)Amount%
Total debt12,93856.2
Stockholders' equity10,08243.8
Total capitalization23,020100.0

323,037,952 shares outstanding at 29 July 2026 (cover page of the 10-Q filed 31 July 2026).

LONG-TERM DEBT 12/31/25

($ millions)Amount
Long-term debt, incl. current maturities12,712
Long-term debt, noncurrent12,124
Current maturities588
Short-term borrowings / commercial paper226

CAPITAL STOCK 12/31/25

Common shares authorized1,275,000,000
Common shares issued322,084,769
Treasury shares18,337,729
Outstanding at 7/29/26323,037,952

DIVIDENDS DECLARED/PAID

Fiscal yearPer share $Payout %
20255.45–
20245.27127.0
20234.9476.5
20224.7039.8
20214.4426.5

HISTORY AND BUSINESS

HISTORY: Incorporated in Netherlands.

BUSINESS: Classified by the SEC under Standard Industrial Classification 2860, Industrial Organic Chemicals. Large accelerated filer. Principal executive office: 2800 Post Oak Blvd, Suite 5100, Houston, TX 77056. Fiscal year ends December 31. For a description of the business, see Item 1 of the latest 10-K.

CONSOLIDATED INCOME ACCOUNT, YEARS ENDED

($ millions)12/31/2512/31/2412/31/23
Revenues30,15333,39433,336
Cost of revenues27,57628,75028,435
Research and development136135130
Selling, general and administrative1,6101,6421,539
Depreciation and amortization1,3901,5221,534
Operating income(420)1,9182,725
Interest expense487481477
Income before income taxes(715)1,7012,299
Income taxes70259433
Net income(738)1,3672,121
Earned per share, diluted ($)(2.34)4.156.46
Dividends per share ($)5.455.274.94

CONSOLIDATED BALANCE SHEET

($ millions)12/31/2512/31/24
Cash and equivalents3,4433,375
Inventories3,5334,658
Total current assets10,86812,266
Property, plant and equipment, net15,83315,066
Goodwill7081,561
Total assets34,00335,746
Total current liabilities6,1296,705
Long-term debt12,12410,532
Stockholders' equity10,08212,462
Total liabilities and equity34,00335,746

TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)

Fiscal year endedRevenuesOper. incomeNet incomeNet margin %EPS diluted $Div. per share $Oper. cash flowCapital expend.Free cash flowTotal assetsTotal liabilitiesTotal debtStockholders' equityROE %Debt / equity
12/31/2530,153(420)(738)-2.4(2.34)5.452,2621,87838434,00323,910d12,93810,082-7.31.28
12/31/2433,3941,9181,3674.14.155.273,8191,8391,98035,74623,272d11,14912,46211.00.89
12/31/2333,3362,7252,1216.46.464.944,9421,5313,41137,00024,056d11,23212,93016.40.87
12/31/2250,4515,1013,8897.711.814.706,1191,8904,22936,36523,736d11,32112,61530.80.90
12/31/2146,1736,7735,61712.216.754.447,6951,9595,73636,74224,870d11,61411,85847.40.98
12/31/2027,7531,5591,4275.14.244.203,4041,9471,45735,40327,415d15,9577,97117.92.00
12/31/1934,7274,1163,3979.89.584.154,9612,6942,26730,43522,372d12,0628,04442.21.50
12/31/1839,0045,2314,69012.012.014.005,4712,1053,36628,27817,998d9,38710,25745.70.92
12/31/1734,4845,4604,87914.112.233.555,2061,5473,65926,20617,256d8,6198,94954.50.96
12/31/1629,1835,0603,83613.19.133.335,6062,2433,36323,44217,369d8,9816,04863.41.48

Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; free cash flow = operating cash flow − purchases of property, plant and equipment; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.

REGISTRANT:

LyondellBasell Industries N.V.
CIK 1489393 · EIN 98-0646235

PRINCIPAL OFFICE:

2800 Post Oak Blvd, Suite 5100, Houston, TX 77056
Tel.: 713-309-7200

INCORPORATED:

Netherlands

INDUSTRY (SEC SIC CODE):

2860 · Industrial Organic Chemicals

FILER STATUS:

Large accelerated filer

LATEST ANNUAL REPORT:

10-K for period ended 12/31/25, filed 20 February 2026

RECENT FILINGS (ANNUAL REPORT REFERENCES BELOW):

7/31/2610-Qperiod 6/30/26
7/31/268-Kperiod 7/31/26
5/29/268-Kperiod 5/29/26
5/22/268-Kperiod 5/22/26
5/1/2610-Qperiod 3/31/26
5/1/268-Kperiod 5/1/26
4/10/26DEF 14Aperiod 5/22/26
2/20/2610-Kperiod 12/31/25

Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2025 (filed 2/20/26) · 10-K FY2024 (filed 2/27/25) · 10-K FY2023 (filed 2/22/24) · 10-K FY2022 (filed 2/23/23) · 10-K FY2019 (filed 2/20/20) · 10-K FY2018 (filed 2/21/19). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.

Data from SEC filings. © 2026 Pathos Investments · pathosinvestments.com · For educational purposes only. Not investment advice.

Data from SEC filings  ·  Educational only  ·  Not investment advice